Cargando…

Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update

The human respiratory syncytial virus (hRSV) is one of the most important causes of upper and lower respiratory tract infections in children and the main cause of bronchiolitis worldwide. Disease manifestations caused by hRSV may vary from mild to severe, occasionally requiring admission and hospita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vázquez, Yaneisi, González, Liliana, Noguera, Loreani, González, Pablo A., Riedel, Claudia A., Bertrand, Pablo, Bueno, Susan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557983/ https://www.ncbi.nlm.nih.gov/pubmed/31214165 http://dx.doi.org/10.3389/fimmu.2019.01154

Ejemplares similares

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
por: Pacheco, Gaspar A., et al.
Publicado: (2023)

Immune-Modulation by the Human Respiratory Syncytial Virus: Focus on Dendritic Cells
por: Tognarelli, Eduardo I., et al.
Publicado: (2019)

Alveolar macrophages and airway hyperresponsiveness associated with respiratory syncytial virus infection
por: Wang, Yuxin, et al.
Publicado: (2022)

Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection
por: Bohmwald, Karen, et al.
Publicado: (2019)

Characterization of the Anti-Inflammatory Capacity of IL-10-Producing Neutrophils in Response to Streptococcus pneumoniae Infection
por: González, Liliana A., et al.
Publicado: (2021)

An update on respiratory syncytial virus
por: Piralla, Antonio, et al.
Publicado: (2023)

Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
por: Antunes, Krist Helen, et al.
Publicado: (2022)

Antiviral activity of extracellular vesicles derived from respiratory syncytial virus-infected airway epithelial cells
por: Corsello, Tiziana, et al.
Publicado: (2022)

Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough-Infected Subjects
por: Duarte, Luisa F, et al.
Publicado: (2023)

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial
por: Abarca, Katia, et al.
Publicado: (2020)

New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus
por: Diethelm-Varela, Benjamín, et al.
Publicado: (2023)

Expanding the Current Knowledge About the Role of Interleukin-10 to Major Concerning Bacteria
por: Peñaloza, Hernán F., et al.
Publicado: (2018)

Cytokine expression in rhinovirus- vs. respiratory syncytial virus-induced first wheezing episode and its relation to clinical course
por: Hurme, Pekka, et al.
Publicado: (2022)

Respiratory Syncytial Virus (RSV) Update
por: Krilov, Leonard R., et al.
Publicado: (2022)

Host Components Contributing to Respiratory Syncytial Virus Pathogenesis
por: Carvajal, Jonatan J., et al.
Publicado: (2019)

Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade
por: Aranda, Sofia S., et al.
Publicado: (2019)

Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus
por: Bohmwald, Karen, et al.
Publicado: (2017)

Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection
por: Glaser, Lena, et al.
Publicado: (2019)

Contribution of Resident Memory CD8(+) T Cells to Protective Immunity against Respiratory Syncytial Virus and Their Impact on Vaccine Design
por: Retamal-Díaz, Angello, et al.
Publicado: (2019)

Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine
por: Russell, Marsha S., et al.
Publicado: (2019)

Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome
por: Fonseca, Wendy, et al.
Publicado: (2018)

Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection
por: Pålsson, Sandra Axberg, et al.
Publicado: (2020)

Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
por: van Erp, Elisabeth A., et al.
Publicado: (2019)

Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus
por: Ascough, Stephanie, et al.
Publicado: (2018)

Early-Life Lung and Gut Microbiota Development and Respiratory Syncytial Virus Infection
por: Yagi, Kazuma, et al.
Publicado: (2022)

Mechanisms of Respiratory Syncytial Virus Modulation of Airway Immune Responses
por: Lotz, Matthew T., et al.
Publicado: (2012)

Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types
por: Atherton, Lydia J., et al.
Publicado: (2019)

A role for airway remodeling during respiratory syncytial virus infection
por: Becnel, David, et al.
Publicado: (2005)

Airway response to respiratory syncytial virus has incidental antibacterial effects
por: Sande, Charles J., et al.
Publicado: (2019)

Antibody development for preventing the human respiratory syncytial virus pathology
por: Soto, Jorge A., et al.
Publicado: (2020)

Respiratory syncytial virus in severe lower respiratory infections in previously healthy young Ethiopian infants
por: Weldetsadik, Abate Yeshidinber, et al.
Publicado: (2021)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
por: Hijano, Diego R., et al.
Publicado: (2019)

Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus
por: Verwey, Charl, et al.
Publicado: (2023)

Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link
por: Piedimonte, Giovanni
Publicado: (2002)

2787. Respiratory Syncytial Virus in Elderly Adults
por: Mykietiuk, Analía, et al.
Publicado: (2019)

Immune escaping of the novel genotypes of human respiratory syncytial virus based on gene sequence variation
por: Zhou, Xiaohe, et al.
Publicado: (2023)

Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy
por: Esposito, Susanna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8evtqr7ep7oi4d4tisnb71bljg